// company-profile

Design Therapeutics, Inc.

DSGN
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings52Insiders14
// api This Design Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Gover Justin D..

// 90-day insight

Over the last 90 days, Design Therapeutics, Inc. insiders bought $0 across 8 transactions with no open-market sales.

  • Most active insider: Shapiro David with 3 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Design Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$391.4M
QoQ change
+17.0%
Reporting period
2026-03-31
#1
SR One Capital Management, LP
CIK 1910264
$69.4M
6.5M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$31.6M
3.0M shares
#3
Point72 Asset Management, L.P.
CIK 1603466
$29.0M
2.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 9, 2026Gover Justin D.DSGN
Award
30,000$0.00$0K
Jun 9, 2026LAPPE RODNEY WDSGN
Award
30,000$0.00$0K
Jun 9, 2026Berger Heather A.DSGN
Award
30,000$0.00$0K
Jun 9, 2026George SimeonDSGN
Award
30,000$0.00$0K
Jun 9, 2026Schmid John P.DSGN
Award
30,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.